Pharmacy
Allergan Acquires Akarna Therapeutics
The FINANCIAL -- Allergan plc on September 20 announced that the Company has acquired Akarna Therapeutics Ltd., a privately held...
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab
The FINANCIAL -- Teva Pharmaceutical Industries Ltd. and Regeneron Pharmaceuticals, Inc. announced on September 20 a global agreement to develop...
Allergan to Acquire Tobira Therapeutics
The FINANCIAL -- Allergan plc and Tobira Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for...
Emma Walmsley to succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline
The FINANCIAL -- GSK on September 20 announces that Emma Walmsley, currently Chief Executive Officer (CEO) of GSK’s Consumer Healthcare...
Bayer sets ambitious growth and earnings aspirations
The FINANCIAL -- The Bayer Group aims to achieve further growth in the coming years and is seeking higher sales...
Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLARO
The FINANCIAL -- Takeda Pharmaceutical Company Limited announced on September 16 that the European Medicines Agency’s (EMA) Committee for Medicinal...
NovoRapid receives positive CHMP opinion for extended use in children as young as one year old
The FINANCIAL -- Novo Nordisk on September 16 announced that the Committee for Medicinal Products for Human Use, CHMP, has...
Pfizer Receives Positive CHMP Opinion For IBRANCE
The FINANCIAL -- Pfizer Inc. on September 16 announced that the Committee for Medicinal Products for Human Use (CHMP) of...
New Novartis data presented at ECTRIMS show benefit of Gilenya on patient disability progression at 10 years
The FINANCIAL -- Novartis on September 16 announced new data from the ACROSS study, which assessed 10-year disability outcomes in...
Sanofi’s Fixed-Ratio Combination Helps More Patients Reach Mealtime Blood Sugar Target than Insulin Glargine Alone
The FINANCIAL -- Sanofi announced on September 13 that iGlarLixi, the investigational, titratable fixed-ratio combination of insulin glargine 100 Units/mL...
AstraZeneca announces two new phase IIIb trials for Forxiga in chronic kidney disease and chronic heart failure
The FINANCIAL -- AstraZeneca on September 12 announced two new randomised, placebo-controlled Phase IIIb outcome trials with Forxiga (dapagliflozin), an...
Takeda and MacroGenics Announce the Conclusion of their MGD010 License and Option Agreement
The FINANCIAL -- MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the...
Sanofi, Alphabet’s Verily Life Create Joint Venture to Treat Diabetes
The FINANCIAL -- Sanofi and Verily Life Sciences LLC, (formerly Google Life Sciences), an Alphabet company, on September 12 announced...
New Novartis point of care Niji(TM) System may provide earlier diagnosis of severe allergic asthma and faster treatment decisions
The FINANCIAL -- Novartis announcedon September 9 the introduction of a novel in office point of care diagnostic tool -...
Bayer and Forschungszentrum Juelich agree on research collaboration
The FINANCIAL -- Bayer and Forschungszentrum Juelich, a member of the Helmholtz Association, have entered into a five-year strategic research...
ADVERTISEMENT
Popular Last 24h
-
RFE/RL: Letter from Congress Urges U.S. Secretary of State Nominee Marco Rubio to Sanction Ivanishvili’s “Enablers”
-
What time is SpaceX’s Starship Flight 7 launch test on Jan. 13?
-
Real Estate in Focus: 2025 Trends to Watch
-
Governor Newsom signs executive order to help Los Angeles rebuild faster and stronger
-
Scope Ratings Revised the Republic of Georgia’s Credit Ratings and Outlooks to Negative
-
IRS announces Jan. 27 start to 2025 tax filing season;
-
Most international migrants don’t move very far from their home countries
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
